In fact, A study by Kiechl et al, concluded serum levels of RANKL/OPG are potential predictors of predisposition and prognosis of breast cancer specially in post-menopausal women (Kiechl, 2017). This evidence concerns the gene TNFSF11 and breast carcinoma.